Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/121503

Beta release

Statistics of Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1 alpha and anti-interleukin-1 beta dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0900
2024-1000
2024-1100